HDT Bio receives Emergency Use Approval for Covid-19 vaccine

HDT Bio has received Emergency Use Approval from the Indian regulators for its Covid-19 vaccine, Gemcovac.

Related Keywords

India , South Korea , Brazil , Gemcovac Covid , Steve Reed , Tablet Press Manufacture For Compaction Simulation , Analytical Services For Biological Assays , Emergency Use Approval , Gennova Biopharmaceuticals , Press Manufacture , Compaction Simulation , Peptide Synthesis , Peptide Libraries ,